²é¿´: 911  |  »Ø¸´: 5
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

wqssfj1

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

[ÇóÖú] ÇóÖú·­Òë

However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience ¡°Localized exfoliation or blisters¡± (frequency not known) were added as the adverse drug reactions in the current CDS.
·ÖÎö¾ä×ӳɷݼӷ­Ò룬лл£¡

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

¾«Æ··­Ò뼯½õ

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qin20010

ľ³æ (СÓÐÃûÆø)

Сľ³æ²©Ê¿Éúµ¼Ê¦

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
sltmac: ½ð±Ò+1 2012-06-26 08:14:20
Ö÷¾äÊÇan evaluation of all reports was performed ºÍLocalized exfoliation or blisters¡± (frequency not known) were added as the adverse drug reactions£¬ÎÒ²»¶®ÖÆÒ©£¬ÄÜÃãÇ¿¶Á¶®¡£
Nothing is difficult to the man who will try
2Â¥2012-06-25 10:59:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wqssfj1

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

Ë­»¹Äܰïæ·­Òëһϣ¬Ð»Ð»ÁË£¡
3Â¥2012-06-25 13:15:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

17953216334

Òø³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
sltmac: ½ð±Ò+1 2012-06-26 08:14:31
È»¶ø,¶ÔÊ×´ÎͶ·ÅÊг¡²¢ÏúÊÛʹÓÃvildagliptin(°üÀ¨GalvusºÍEucreas)µ½2012Äê2ÔÂ29ÈÕ¼äNovartis ÊÕµ½µÄÓëÆ¤·ôʼþÏà¹ØµÄ±¨µÀ½øÐÐÁËÆÀ¹À,ÔÚµ±Ç°µÄ CDS ÖÐÒòΪҩƷ²»Á¼·´Ó¦£¬ÉÏÊк󡱾ֲ¿ÍÑÆ¤»òË®ÅÝ¡±(ƵÂʲ»ÖªµÀ)Çé¿öÔö¶à¡£    ³É·Ö·ÖÎöͬÒâ2Â¥¿´·¨
4Â¥2012-06-25 13:24:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

readbycandle

ľ³æ (ÖøÃûдÊÖ)

A thinking worm

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience ¡°Localized exfoliation or blisters¡± (frequency not known) were added as the adverse drug reactions in the current CDS.
ÕâÊÇÁ½¸ö²¢Áеľä×Ó¡£an evaluationketed....was performed and ¡°Localized exfoliation or blisters¡±  were added .
·­Ò룺
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed
²»¹ý£¬ÒѶÔ×ÔͶ·ÅÊг¡ÒÔÀ´ÖÁ2012Äê2ÔÂ29ÈÕŵ»ª¹«Ë¾ÊÕµ½µÄ¹ØÓÚʹÓÃvildagliptin (°üÀ¨Galvus and Eucreas)ÒýÆðµÄƤ·ô·´Ó¦µÄËùÓб¨¸æ½øÐÐÁËÆÀ¹À£¬

and as post-marketing experience ¡°Localized exfoliation or blisters¡± (frequency not known) were added as the adverse drug reactions in the current CDS.
²¢½«¡°¿ÉÒÔÒýÆð¾Ö²¿ÍÑÆ¤»òË®ÅÝ¡±×÷ΪÊг¡·´À¡ÐÅÏ¢¼ÓÈëĿǰCDSµÄ¸±×÷ÓÃ˵Ã÷ÖС£
5Â¥2012-06-28 17:36:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

readbycandle

ľ³æ (ÖøÃûдÊÖ)

A thinking worm

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
wqssfj1: ½ð±Ò+5, ·­ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú 2012-07-13 18:44:34
¶Ô²»Æð£¬Óм¸´¦Â©×Ö¡£Ô­Ìû²»Èøģ¬Ôٻظ´Ò»´ÎÀ²£º
ÕâÊÇÁ½¸ö²¢Áеľä×Ó¡£an evaluation....was performed and ¡°Localized exfoliation or blisters¡±  were added .
·­Ò룺
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed
²»¹ý£¬ÒѶÔ×ÔͶ·ÅÊг¡ÒÔÀ´ÖÁ2012Äê2ÔÂ29ÈÕŵ»ª¹«Ë¾ÊÕµ½µÄ¹ØÓÚʹÓÃvildagliptin (°üÀ¨Galvus and Eucreas)ÒýÆðµÄƤ·ô·´Ó¦µÄËùÓб¨¸æ½øÐÐÁËÆÀ¹À£¬

and as post-marketing experience ¡°Localized exfoliation or blisters¡± (frequency not known) were added as the adverse drug reactions in the current CDS.
²¢½«¡°¿ÉÒÔÒýÆð¾Ö²¿ÍÑÆ¤»òË®ÅÝ(¸ÅÂÊδ֪)¡±×÷ΪÊг¡·´À¡ÐÅÏ¢¼ÓÈëĿǰCDSµÄ¸±×÷ÓÃ˵Ã÷ÖС£
6Â¥2012-06-28 17:46:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ wqssfj1 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 303Çóµ÷¼Á +4 ԪϦԪ 2026-03-20 5/250 2026-03-25 00:20 by ԪϦԪ
[¿¼ÑÐ] Çóµ÷¼Á323²ÄÁÏÓ뻯¹¤ +3 1124361 2026-03-24 3/150 2026-03-24 20:24 by peike
[¿¼ÑÐ] ÉúÎïѧѧ˶Çóµ÷¼Á +6 СÑò˯×ÅÁË? 2026-03-23 9/450 2026-03-24 20:21 by СÑò˯×ÅÁË?
[¿¼ÑÐ] ²ÄÁÏר˶ÕÒµ÷¼Á +5 ¹þ¹þ¹þºðºðºð¹þ 2026-03-23 5/250 2026-03-24 19:07 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] 070300»¯Ñ§Çóµ÷¼Á +9 Ô·¶¹¶¹ 2026-03-20 9/450 2026-03-24 17:15 by licg0208
[¿¼ÑÐ] 299Çóµ÷¼Á +7 ijijijijλ 2026-03-21 7/350 2026-03-24 15:24 by cuifj
[¿¼ÑÐ] һ־Ըɽ¶«´óѧҩѧѧ˶Çóµ÷¼Á +3 ¿ª¿ªÐÄÐÄû·³ÄÕ 2026-03-23 4/200 2026-03-24 00:06 by ¿ª¿ªÐÄÐÄû·³ÄÕ
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +4 ÄÌÓͲÝÝ®. 2026-03-22 5/250 2026-03-23 19:37 by pswait
[¿¼ÑÐ] 291 Çóµ÷¼Á +4 »¯¹¤2026½ì±ÏÒµÉ 2026-03-21 5/250 2026-03-23 16:46 by »¯¹¤2026½ì±ÏÒµÉ
[¿¼ÑÐ] 306Çóµ÷¼Á +5 À´ºÃÔËÀ´À´À´ 2026-03-22 5/250 2026-03-22 16:17 by BruceLiu320
[¿¼ÑÐ] 354Çóµ÷¼Á +7 Tyoumou 2026-03-18 10/500 2026-03-22 11:11 by ÈËÀ´Ê¢
[¿¼ÑÐ] ³õÊÔ 317 +7 °ëÀ­Ô±û 2026-03-20 7/350 2026-03-21 22:26 by peike
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 ºôºô£¿~+123456 2026-03-21 3/150 2026-03-21 20:04 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 265Çóµ÷¼Á +12 ÁºÁºÐ£Ð£ 2026-03-19 14/700 2026-03-21 13:38 by lature00
[¿¼ÑÐ] 332Çóµ÷¼Á +3 ·ï»ËÔº¶¡Õæ 2026-03-20 3/150 2026-03-21 10:27 by luoyongfeng
[¿¼ÑÐ] 085601µ÷¼Á 358·Ö +3 zzzzggh 2026-03-20 4/200 2026-03-21 10:21 by luoyongfeng
[¿¼ÑÐ] 288Çóµ÷¼Á +16 ÓÚº£º£º£º£ 2026-03-19 16/800 2026-03-20 22:28 by JourneyLucky
[¿¼ÑÐ] 317Çóµ÷¼Á +5 Éê×ÓÉêÉê 2026-03-19 9/450 2026-03-20 22:26 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤ 322Çóµ÷¼Á +4 È»11 2026-03-19 4/200 2026-03-20 22:12 by luoyongfeng
[¿¼ÑÐ] Çóµ÷¼Á +3 @taotao 2026-03-20 3/150 2026-03-20 19:35 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û